SPIKEVAX 0.2 mg/ml, injectable dispersion. mRNA vaccine against COVID-19 10 bottles
Active ingredients: ÉLASOMÉRAN
Commercialized according to BDPMDispensing in France: Prescription only
Injectable dispersion10 bottlesintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIKEVAX 0,2 mg/mL, dispersion injectable. Vaccin à ARNm contre la COVID-19
- Pharmaceutical form
- dispersion injectable
- Route of administration
- intramusculaire
- Presentation description
- 10 flacon(s) multidose(s) en verre
- Marketing authorisation holder
- MODERNA BIOTECH SPAIN SL (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66689795CIP73021955CIP133400930219553Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉLASOMÉRANdispersion | 100 microgrammes · une dose de 0,5 mL ou 50 microgrammes pour une dose de 0,25 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.